Cargando…

Expected RATE of Vaccine-Associated Paralytic Poliomyelitis: A Simulation Analysis Regarding Transition from the Trivalent to Bivalent Oral Poliovirus Vaccine

Detalles Bibliográficos
Autores principales:	Yasri, Sora, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356969/ https://www.ncbi.nlm.nih.gov/pubmed/34447491 http://dx.doi.org/10.4103/ijpvm.IJPVM_293_19

Ejemplares similares

Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine — Worldwide, 2013–2016
Publicado: (2015)

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
por: Bahl, Sunil, et al.
Publicado: (2017)

Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016
por: Zhao, Dan, et al.
Publicado: (2017)

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
por: Tevi-Benissan, Carol, et al.
Publicado: (2017)

An unusual case of vaccine-associated paralytic poliomyelitis
por: Desai, S, et al.
Publicado: (2014)

Cost-Effectiveness of Varicella Vaccination
por: Yasri, Sora, et al.
Publicado: (2019)

Subacute thyroiditis after COVID-19 vaccination
por: Yasri, Sora, et al.
Publicado: (2022)

Subacute thyroiditis after COVID-19 vaccination
por: Yasri, Sora, et al.
Publicado: (2022)

COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
por: Yasri, Sora, et al.
Publicado: (2022)

Expected Under-Recorded Incidence of Dengue in Thailand–Myanmar Border Provinces
por: Yasri, Sora, et al.
Publicado: (2019)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

New COVID-19 Vaccine: What about Cost and Utility?
por: Yasri, Sora, et al.
Publicado: (2022)

NON-PARALYTIC POLIOMYELITIS IN THE CHIMPANZEE
por: Bodian, David, et al.
Publicado: (1945)

Venereal disease research laboratory serology after COVID-19 vaccination: The first report
por: Yasri, Sora, et al.
Publicado: (2022)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Exported Wuhan Novel Coronavirus Infection: An Expected Rate with Reference to Main Destination of Chinese Tourist, Thailand
por: Yasri, Sora, et al.
Publicado: (2020)

Vaccine-associated Paralytic Poliomyelitis in Immunodeficient Children, Iran, 1995–2008
por: Shahmahmoodi, Shohreh, et al.
Publicado: (2010)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Vaccine-associated Paralytic Poliomyelitis : A Case Report of Flaccid Monoparesis after Oral Polio Vaccine
por: Kim, Sun Jun, et al.
Publicado: (2007)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia
por: Holmes, Marionette, et al.
Publicado: (2017)

AN EPIDEMIC OF PARALYTIC POLIOMYELITIS CHARACTERIZED BY DUAL INFECTIONS WITH POLIOMYELITIS AND COXSACKIE VIRUSES
por: Melnick, Joseph L., et al.
Publicado: (1951)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Environmental Surveillance of Polioviruses in Armenia, Colombia before Trivalent Oral Polio Vaccine Cessation
por: González, María Mercedes, et al.
Publicado: (2019)

Vaccine-Associated Paralytic Poliomyelitis — 8 PLADs, China, October 2012–March 2014
por: Wen, Ning, et al.
Publicado: (2020)

Total Hip Arthroplasty for the Paralytic and Non-paralytic Side in Patient with Residual Poliomyelitis
por: Sonohata, Motoki, et al.
Publicado: (2016)

The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

NATURE OF NON-PARALYTIC AND TRANSITORY PARALYTIC POLIOMYELITIS IN RHESUS MONKEYS INOCULATED WITH HUMAN VIRUS
por: Sabin, Albert B., et al.
Publicado: (1941)

Information on vaccination safety on internet
por: Yasri, Sora, et al.
Publicado: (2018)

Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022
por: Link-Gelles, Ruth, et al.
Publicado: (2022)

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

I. Foreword-With a Review of the Past Experiences of the Yale Poliomyelitis Study Unit with Oral Poliovirus Vaccines
por: Paul, John R.
Publicado: (1962)

Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis
por: Halpern, Meira S, et al.
Publicado: (2018)

Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine—Lessons Learned
por: Shendale, Stephanie, et al.
Publicado: (2017)

Postpolio Syndrome from Non-paralytic Poliovirus Infection
por: Maeda, Kengo, et al.
Publicado: (2022)

Regulatory Aspects of Sabin Type 2 Withdrawal From Trivalent Oral Poliovirus Vaccine: Process and Lessons Learned
por: Decina, Daniela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1e6glgpt6b0b4gpe9qifmu7too